The economic burden of breast cancer in India will exceed $13 billion by 2030.

CHENNAI Chennai: With an increase of 50,000 cases of breast cancer every year, the economic burden is also likely to increase from 2021 to 2030. The total economic burden of breast cancer in India is estimated to be $8 billion in 2021, and is projected to increase to $13.96 billion by 2030, according to a recent study published in the journal Nature.'Economic burden of breast cancer in India, 2000- The study titled 'Projections to 2021 and 2030' used data from the Global Burden of Disease Database to estimate the annual prevalence of breast cancer.

The study said that the prevalence of breast cancer and its economic impact are projected to increase substantially in India. Between 2021 and 2030, the number of patients is expected to increase by approximately 0.05 million each year, an annual growth rate of approximately 5.6%. The associated economic burden will also increase, averaging $19.55 billion/year, underscoring the need for intensive healthcare and economic strategies.

Narasima MS, assistant professor at the Great Lakes Institute of Management, one of the authors of the study, said: “There is not enough awareness about it, because the general perception is that it will not affect them. However, late detection increases mortality. “Premature mortality of patients also puts a burden on the economy as their contribution to GDP also goes away.”

He said the study's findings were important for Tamil Nadu, which accounts for 6.13% of India's female population and 10.05% of the working female population. The state's net state domestic product, which is 30.16%, is higher than the country's GDP, which translates into an economic burden. The population of working women between the ages of 20 and 60 in Tamil Nadu is 37.05%, much higher than the national average of 25.17%.

Professor Narasimha said, “The increase in the number of breast cancer cases in India over the last 20 years has prompted a lot of research. It is more likely than western countries due to several reasons such as early onset, delayed diagnosis, poor management and inadequate treatment. “Survival rates among Indian women are low.” The study also notes that forecasts can be used to plan investments in health infrastructure, medical staff training and patient support services. The model used to make forecasts also attempts to guide policymakers in preparing healthcare budgets with adequate funding to manage the growing burden. Introducing and promoting early detection techniques can lead to early diagnosis, which can reduce treatment costs and improve survival rates.

Comments are closed.